The new coronavirus pandemic poses question and challenges for dermatologists. One of question is if psoriasis patients treated with immunomodulating and immunosuppressive drugs have to discontinue their treatment in the midts of fears for the infection and its consequences. One of the challenges is how can we support our patients in this critical time. Previous coronaviruses outbreaks reports, current published evidences on pathogenesis and on clinical reports of COVID infection in immunosuppressed patients are used to make a scientifically based decision. This article is protected by copyright. All rights reserved.

COVID-19 and psoriasis: Should we fear for patients treated with biologics?

Amerio, Paolo
;
Giuliani, Federica;Gualdi, Giulio
2020-01-01

Abstract

The new coronavirus pandemic poses question and challenges for dermatologists. One of question is if psoriasis patients treated with immunomodulating and immunosuppressive drugs have to discontinue their treatment in the midts of fears for the infection and its consequences. One of the challenges is how can we support our patients in this critical time. Previous coronaviruses outbreaks reports, current published evidences on pathogenesis and on clinical reports of COVID infection in immunosuppressed patients are used to make a scientifically based decision. This article is protected by copyright. All rights reserved.
File in questo prodotto:
File Dimensione Formato  
dth.13434.pdf

Solo gestori archivio

Descrizione: Review Article
Tipologia: PDF editoriale
Dimensione 574.41 kB
Formato Adobe PDF
574.41 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11564/738763
Citazioni
  • ???jsp.display-item.citation.pmc??? 21
  • Scopus 39
  • ???jsp.display-item.citation.isi??? 33
social impact